Lv31
354 积分 2023-07-31 加入
CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas
26天前
已完结
Role of the Programmed Death-1 Pathway in Regulation of Alloimmune Responses In Vivo
29天前
已完结
Targeting CD47 Enhanced the Antitumor Immunity of PD-L1 Blockade in B-Cell Lymphoma
1个月前
已完结
Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-Dioxygenase
1个月前
已完结
Open-Label, Phase II Study of Talimogene Laherparepvec Plus Pembrolizumab for the Treatment of Advanced Melanoma That Progressed on Prior Anti–PD-1 Therapy: MASTERKEY-115,
1个月前
已完结
Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells
1个月前
已完结
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
2个月前
已完结
Paradigms on Immunotherapy Combinations with Chemotherapy
2个月前
已完结
OX40 enhances T cell immune response to PD-1 blockade therapy in non-small cell lung cancer
7个月前
已完结
Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance
7个月前
已完结
皖公网安备34019202002308
